Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
ARS Pharmaceuticals Inc
Swot
ARS Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
ARS Pharmaceuticals Inc has 11 Strengths, 6 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(6)
Opportunity
(1)
Threats
(2)
Others
(1)
Rising Momentum: Momentum Score Weekly Gainers
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Top Gainers
Stock with Low PE (PE < = 10)
Stocks with Quarter Change % less than Industry
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Declining profits every quarter for the past 3 quarters
Stocks Underperforming their Industry Price Change in the Quarter
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
